Skip to main content
Erschienen in: Pediatric Cardiology 8/2016

09.07.2016 | Original Article

Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease

verfasst von: Lucy Youngmin Eun, Ji Hong Kim, Jo Won Jung, Jae Young Choi

Erschienen in: Pediatric Cardiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Recently, the prevalence of infant Kawasaki disease (KD) has increased. However, the myocardial functional analysis of infant KD can be difficult and rarely reported. The purpose of this study was to investigate layer specific myocardial strain analysis for better assessment of the acute period in infant KD. The study retrospectively reviewed the echocardiographic data of 25 infant patients with KD at the acute phase. With advanced imaging, pulsed tissue Doppler velocity data, myocardial strain with three layers specific analysis was performed. Then the data were compared with 25 age-matched healthy control infants. The measures of longitudinal strain and radial strain were decreased in infant KD compared to healthy controls. The circumferential strain was significantly decreased in infant KD at all three myocardial layers, especially in the endocardial layer (KD: −20.5 ± 6.4 % vs. control: −25.6 ± 7.6 %, endocardium, p = 0.00001; −14.6 ± 4.4 % vs. −18.1 ± 4.0 %; middle myocardium, p = 0.01; −9.7 ± 3.3 % vs. −11.4 ± 3.8 %; epicardium, p = 0.04). The acute phase of infant KD demonstrated decreased myocardial strain measurement. Circumferential strain was the lowest in the endocardial layer. Further continuous long-term follow up for myocardial assessment should be recommended even after recovery with appropriate treatment.
Literatur
1.
Zurück zum Zitat Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100–107PubMed Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100–107PubMed
2.
Zurück zum Zitat Takahashi M (1989) Myocarditis in Kawasaki syndrome: A minor villain? Circulation 79:1398–1400CrossRefPubMed Takahashi M (1989) Myocarditis in Kawasaki syndrome: A minor villain? Circulation 79:1398–1400CrossRefPubMed
3.
Zurück zum Zitat Kurotobi S, Kawakami N, Shimizu K et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430CrossRefPubMed Kurotobi S, Kawakami N, Shimizu K et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430CrossRefPubMed
4.
Zurück zum Zitat Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362CrossRefPubMed Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362CrossRefPubMed
5.
Zurück zum Zitat Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y (2003) Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325–330CrossRefPubMed Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y (2003) Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325–330CrossRefPubMed
6.
Zurück zum Zitat Yu JJ, Kwak BO, Jeon YH, Park YM, Lee R, Chung S, Bae SH, Pyun BY (2009) Elevation of the index of left ventricular mass during the acute and subacute phase of Kawasaki disease, and its association with indexes of diastolic function. Cardiol Young 19:64–69CrossRefPubMed Yu JJ, Kwak BO, Jeon YH, Park YM, Lee R, Chung S, Bae SH, Pyun BY (2009) Elevation of the index of left ventricular mass during the acute and subacute phase of Kawasaki disease, and its association with indexes of diastolic function. Cardiol Young 19:64–69CrossRefPubMed
7.
Zurück zum Zitat McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon SC (2013) Myocardial strain and strain rate in Kawasaki disease. Eur Heart J 14:1061–1068 McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon SC (2013) Myocardial strain and strain rate in Kawasaki disease. Eur Heart J 14:1061–1068
8.
Zurück zum Zitat Dandel M, Hetzer R (2009) Echocardiographic strain and strain rate imaging: clinical applications. Int J Cardiol 132:11–24CrossRefPubMed Dandel M, Hetzer R (2009) Echocardiographic strain and strain rate imaging: clinical applications. Int J Cardiol 132:11–24CrossRefPubMed
9.
Zurück zum Zitat Dahifar H, Ghorbani A (2005) Atypical Kawasaki disease in two infants younger than 6 months. J Res Med Sci 10(4):239–243 Dahifar H, Ghorbani A (2005) Atypical Kawasaki disease in two infants younger than 6 months. J Res Med Sci 10(4):239–243
10.
Zurück zum Zitat Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association Guidelines. Am Fam Phys 74:1141–1148 Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association Guidelines. Am Fam Phys 74:1141–1148
11.
Zurück zum Zitat Shulman ST, Mcauley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425PubMed Shulman ST, Mcauley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425PubMed
12.
Zurück zum Zitat Tseng CF, Fu YC, Fu LS, Hwang B, Chi CS (2001) Clinical spectrum of Kawasaki disease in infants. Chin Med J 64:168–173 Tseng CF, Fu YC, Fu LS, Hwang B, Chi CS (2001) Clinical spectrum of Kawasaki disease in infants. Chin Med J 64:168–173
13.
Zurück zum Zitat Liu HC, Lo CW, Hwang B, Lee PC (2012) Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. Sci World J 15:1–6 Liu HC, Lo CW, Hwang B, Lee PC (2012) Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. Sci World J 15:1–6
14.
Zurück zum Zitat Burns JC, Wiggins JW, Toews WH (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763CrossRefPubMed Burns JC, Wiggins JW, Toews WH (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763CrossRefPubMed
15.
Zurück zum Zitat Rosenfeld EA, Corydon KE, Shulman ST, Mason W, Takahashi M, Kuroda C (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529CrossRefPubMed Rosenfeld EA, Corydon KE, Shulman ST, Mason W, Takahashi M, Kuroda C (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529CrossRefPubMed
16.
Zurück zum Zitat Anderson MS, Todd JK, Glode MP (2005) Delayed diagnosis of Kawasaki disease syndrome: an analysis of the problem. Pediatrics 115:e428–e433CrossRefPubMed Anderson MS, Todd JK, Glode MP (2005) Delayed diagnosis of Kawasaki disease syndrome: an analysis of the problem. Pediatrics 115:e428–e433CrossRefPubMed
17.
Zurück zum Zitat Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391PubMed Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391PubMed
18.
Zurück zum Zitat Moreno N, Mendez-Echevarria A, Inocencio J (2008) Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin. Pediatr Cardiol 29:31–35CrossRefPubMed Moreno N, Mendez-Echevarria A, Inocencio J (2008) Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin. Pediatr Cardiol 29:31–35CrossRefPubMed
19.
Zurück zum Zitat Chang FY, Hwang B, Chen SJ, Lee PC, Meng CL, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis 25:241–244CrossRef Chang FY, Hwang B, Chen SJ, Lee PC, Meng CL, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis 25:241–244CrossRef
20.
Zurück zum Zitat Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW (2009) Kawasaki disease at the extremes of the age spectrum. Pediatrics 124:e410–e415CrossRefPubMed Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW (2009) Kawasaki disease at the extremes of the age spectrum. Pediatrics 124:e410–e415CrossRefPubMed
21.
Zurück zum Zitat Joffe A, Kabani A, Jadavji T (1995) Atypical and complicated Kawasaki disease in infants—Do we need criteria? West J Med 162:322–327PubMedPubMedCentral Joffe A, Kabani A, Jadavji T (1995) Atypical and complicated Kawasaki disease in infants—Do we need criteria? West J Med 162:322–327PubMedPubMedCentral
22.
Zurück zum Zitat Levy M, Koren G (1990) Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 9:122–126CrossRefPubMed Levy M, Koren G (1990) Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 9:122–126CrossRefPubMed
23.
Zurück zum Zitat Schuh S, Laxer RM, Smallhorn JF, Hilliard RI, Rowe RD (1988) Kawasaki disease with atypical presentation. Pediatr Infect Dis J 7:201–203CrossRefPubMed Schuh S, Laxer RM, Smallhorn JF, Hilliard RI, Rowe RD (1988) Kawasaki disease with atypical presentation. Pediatr Infect Dis J 7:201–203CrossRefPubMed
24.
Zurück zum Zitat Friedman AD (1988) An atypical presentation of Kawasaki disease in an infant. Pediatr Dermatol 5:120–122CrossRefPubMed Friedman AD (1988) An atypical presentation of Kawasaki disease in an infant. Pediatr Dermatol 5:120–122CrossRefPubMed
25.
Zurück zum Zitat Reller M, DeCristofaro J, Schwartz DC (1984) Coronary aneurysms in a patient with atypical Kawaski disease and a streptococcal infection. Pediatr Cardiol 5:205–208CrossRefPubMed Reller M, DeCristofaro J, Schwartz DC (1984) Coronary aneurysms in a patient with atypical Kawaski disease and a streptococcal infection. Pediatr Cardiol 5:205–208CrossRefPubMed
26.
Zurück zum Zitat Kurotobi S, Kawakami N, Shimizu K et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430CrossRefPubMed Kurotobi S, Kawakami N, Shimizu K et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430CrossRefPubMed
27.
Zurück zum Zitat Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362CrossRefPubMed Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362CrossRefPubMed
28.
Zurück zum Zitat Arnold R, Goebel B, Ulmer HE, Gorenflo M, Poerner TC (2007) An exercise tissue Doppler and strain rate imaging study of diastolic myocardial dysfunction after Kawasaki syndrome in childhood. Cardiol Young 17:478–486CrossRefPubMed Arnold R, Goebel B, Ulmer HE, Gorenflo M, Poerner TC (2007) An exercise tissue Doppler and strain rate imaging study of diastolic myocardial dysfunction after Kawasaki syndrome in childhood. Cardiol Young 17:478–486CrossRefPubMed
29.
Zurück zum Zitat McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179CrossRefPubMed McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179CrossRefPubMed
30.
Zurück zum Zitat Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249CrossRefPubMed Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249CrossRefPubMed
31.
Zurück zum Zitat Dallaire F, Fournier A, Breton J, Nguyen TD, Spigelblatt L, Dahdah N (2012) Marked variations in serial coronary artery diameter measures in Kawasaki disease: a new indicator of coronary involvement. J Am Soc Echocardiogr 25:859–865CrossRefPubMed Dallaire F, Fournier A, Breton J, Nguyen TD, Spigelblatt L, Dahdah N (2012) Marked variations in serial coronary artery diameter measures in Kawasaki disease: a new indicator of coronary involvement. J Am Soc Echocardiogr 25:859–865CrossRefPubMed
32.
Zurück zum Zitat Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD (2000) Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 139(2 Pt 1):217–223PubMed Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD (2000) Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 139(2 Pt 1):217–223PubMed
33.
Zurück zum Zitat Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakazawa K (1981) Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 47(2):323–330CrossRefPubMed Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakazawa K (1981) Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 47(2):323–330CrossRefPubMed
34.
Zurück zum Zitat Yu JJ, Choi HS, Kim YB, Son JS, Kim YH, Ko JK, Park IS (2010) Analysis of left ventricular myocardial deformation by speckle tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol 31:807–812CrossRefPubMed Yu JJ, Choi HS, Kim YB, Son JS, Kim YH, Ko JK, Park IS (2010) Analysis of left ventricular myocardial deformation by speckle tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol 31:807–812CrossRefPubMed
35.
Zurück zum Zitat Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome. Circulation 79:1237–1246CrossRefPubMed Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome. Circulation 79:1237–1246CrossRefPubMed
36.
Zurück zum Zitat Henry WL, Ware J, Gardin JM, Hepner SI, McKay J, Weiner M (1987) Echocardiographic measurements in normal subjects: Growth-related changes that occur between infancy and early adulthood. Circulation 7:278–285 Henry WL, Ware J, Gardin JM, Hepner SI, McKay J, Weiner M (1987) Echocardiographic measurements in normal subjects: Growth-related changes that occur between infancy and early adulthood. Circulation 7:278–285
37.
Zurück zum Zitat Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD (2011) Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 57:86–92CrossRefPubMedPubMedCentral Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD (2011) Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 57:86–92CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Lega JC, Bozio A, Cimaz R, Verier M, Floret D, Ducreux C, Reix P, Filippo S (2013) Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. Arch Dis Child 98:97–102CrossRefPubMed Lega JC, Bozio A, Cimaz R, Verier M, Floret D, Ducreux C, Reix P, Filippo S (2013) Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. Arch Dis Child 98:97–102CrossRefPubMed
39.
Zurück zum Zitat No SJ, Kim DO, Choi KM, Eun LY (2013) Do predictors of incomplete Kawasaki disease exists for infants? Pediatr Cardiol 34:286–290CrossRefPubMed No SJ, Kim DO, Choi KM, Eun LY (2013) Do predictors of incomplete Kawasaki disease exists for infants? Pediatr Cardiol 34:286–290CrossRefPubMed
Metadaten
Titel
Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease
verfasst von
Lucy Youngmin Eun
Ji Hong Kim
Jo Won Jung
Jae Young Choi
Publikationsdatum
09.07.2016
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2016
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-016-1448-x

Weitere Artikel der Ausgabe 8/2016

Pediatric Cardiology 8/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.